408 related articles for article (PubMed ID: 19998480)
1. Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia.
Butchi NB; Du M; Peterson KE
Glia; 2010 Apr; 58(6):650-64. PubMed ID: 19998480
[TBL] [Abstract][Full Text] [Related]
2. The early induction of suppressor of cytokine signaling 1 and the downregulation of toll-like receptors 7 and 9 induce tolerance in costimulated macrophages.
Lee HJ; Kim KC; Han JA; Choi SS; Jung YJ
Mol Cells; 2015 Jan; 38(1):26-32. PubMed ID: 25518931
[TBL] [Abstract][Full Text] [Related]
3. Innate immune responses after stimulation with Toll-like receptor agonists in ex vivo microglial cultures and an in vivo model using mice with reduced microglia.
Carroll JA; Race B; Williams K; Striebel JF; Chesebro B
J Neuroinflammation; 2021 Sep; 18(1):194. PubMed ID: 34488805
[TBL] [Abstract][Full Text] [Related]
4. IL-4 suppresses the responses to TLR7 and TLR9 stimulation and increases the permissiveness to retroviral infection of murine conventional dendritic cells.
Sriram U; Xu J; Chain RW; Varghese L; Chakhtoura M; Bennett HL; Zoltick PW; Gallucci S
PLoS One; 2014; 9(1):e87668. PubMed ID: 24489947
[TBL] [Abstract][Full Text] [Related]
5. TLR9-Activating CpG-B ODN but Not TLR7 Agonists Triggers Antibody Formation to Factor IX in Muscle Gene Transfer.
Butterfield JSS; Biswas M; Shirley JL; Kumar SRP; Sherman A; Terhorst C; Ling C; Herzog RW
Hum Gene Ther Methods; 2019 Jun; 30(3):81-92. PubMed ID: 31140323
[TBL] [Abstract][Full Text] [Related]
6. Guanine-modified inhibitory oligonucleotides efficiently impair TLR7- and TLR9-mediated immune responses of human immune cells.
Römmler F; Hammel M; Waldhuber A; Müller T; Jurk M; Uhlmann E; Wagner H; Vollmer J; Miethke T
PLoS One; 2015; 10(2):e0116703. PubMed ID: 25695778
[TBL] [Abstract][Full Text] [Related]
7. TLR7 and TLR9 trigger distinct neuroinflammatory responses in the CNS.
Butchi NB; Woods T; Du M; Morgan TW; Peterson KE
Am J Pathol; 2011 Aug; 179(2):783-94. PubMed ID: 21801870
[TBL] [Abstract][Full Text] [Related]
8. Natural and synthetic TLR7 ligands inhibit CpG-A- and CpG-C-oligodeoxynucleotide-induced IFN-alpha production.
Berghöfer B; Haley G; Frommer T; Bein G; Hackstein H
J Immunol; 2007 Apr; 178(7):4072-9. PubMed ID: 17371961
[TBL] [Abstract][Full Text] [Related]
9. Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells.
Wang J; Lau KY; Jung J; Ravindran P; Barrat FJ
Eur J Immunol; 2014 Apr; 44(4):1130-6. PubMed ID: 24375473
[TBL] [Abstract][Full Text] [Related]
10. Nucleic Acid-Sensing Toll-Like Receptors Play a Dominant Role in Innate Immune Recognition of Pneumococci.
Famà A; Midiri A; Mancuso G; Biondo C; Lentini G; Galbo R; Giardina MM; De Gaetano GV; Romeo L; Teti G; Beninati C
mBio; 2020 Mar; 11(2):. PubMed ID: 32209688
[No Abstract] [Full Text] [Related]
11. Additive melanoma suppression with intralesional phospholipid-conjugated TLR7 agonists and systemic IL-2.
Hayashi T; Chan M; Norton JT; Wu CC; Yao S; Cottam HB; Tawatao RI; Corr M; Carson DA; Daniels GA
Melanoma Res; 2011 Feb; 21(1):66-75. PubMed ID: 21030882
[TBL] [Abstract][Full Text] [Related]
12. TLR7 is a key regulator of innate immunity against Japanese encephalitis virus infection.
Nazmi A; Mukherjee S; Kundu K; Dutta K; Mahadevan A; Shankar SK; Basu A
Neurobiol Dis; 2014 Sep; 69():235-47. PubMed ID: 24909816
[TBL] [Abstract][Full Text] [Related]
13. A human microsatellite DNA-mimicking oligodeoxynucleotide with CCT repeats negatively regulates TLR7/9-mediated innate immune responses via selected TLR pathways.
Sun R; Sun L; Bao M; Zhang Y; Wang L; Wu X; Hu D; Liu Y; Yu Y; Wang L
Clin Immunol; 2010 Mar; 134(3):262-76. PubMed ID: 20034855
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 4, Toll-like receptor 7 and Toll-like receptor 9 agonists enhance immune responses against blood-stage Plasmodium chabaudi infection in BALB/c mice.
Gao W; Sun X; Li D; Sun L; He Y; Wei H; Jin F; Cao Y
Int Immunopharmacol; 2020 Dec; 89(Pt B):107096. PubMed ID: 33091818
[TBL] [Abstract][Full Text] [Related]
15. Persistent Toll-like receptor 7 stimulation induces behavioral and molecular innate immune tolerance.
Michaelis KA; Norgard MA; Levasseur PR; Olson B; Burfeind KG; Buenafe AC; Zhu X; Jeng S; McWeeney SK; Marks DL
Brain Behav Immun; 2019 Nov; 82():338-353. PubMed ID: 31499172
[TBL] [Abstract][Full Text] [Related]
16. TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity.
Johnson TR; Rao S; Seder RA; Chen M; Graham BS
Vaccine; 2009 May; 27(23):3045-52. PubMed ID: 19428918
[TBL] [Abstract][Full Text] [Related]
17. Toll like receptor 9 antagonism modulates spinal cord neuronal function and survival: Direct versus astrocyte-mediated mechanisms.
Acioglu C; Mirabelli E; Baykal AT; Ni L; Ratnayake A; Heary RF; Elkabes S
Brain Behav Immun; 2016 Aug; 56():310-24. PubMed ID: 27044334
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the neuroinflammatory response to TLR7 stimulation in the brain: comparison of multiple TLR7 and/or TLR8 agonists.
Butchi NB; Pourciau S; Du M; Morgan TW; Peterson KE
J Immunol; 2008 Jun; 180(11):7604-12. PubMed ID: 18490763
[TBL] [Abstract][Full Text] [Related]
19. Comparison of human B cell activation by TLR7 and TLR9 agonists.
Hanten JA; Vasilakos JP; Riter CL; Neys L; Lipson KE; Alkan SS; Birmachu W
BMC Immunol; 2008 Jul; 9():39. PubMed ID: 18652679
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 7 stimulation by imiquimod induces macrophage autophagy and inflammation in atherosclerotic plaques.
De Meyer I; Martinet W; Schrijvers DM; Timmermans JP; Bult H; De Meyer GR
Basic Res Cardiol; 2012 May; 107(3):269. PubMed ID: 22543675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
